Profile data is unavailable for this security.
About the company
Wuhan YZY Biopharma Co Ltd is a China-based company principally engaged in the research, development, production and sales of pharmaceuticals. The Company is mainly engaged in the research, development and industrialization of bispecific antibody drugs. The Company's main products include anti-PD1&anti-CD3, anti-CD19&anti-CD3, and anti-CDX&CD3. The Company's drug products are mainly used in major diseases such as tumor, immunity, inflammation, cardiovascular and infection.
- Revenue in HKD (TTM)0.00
- Net income in HKD-199.71m
- Incorporated2010
- Employees114.00
- LocationWuhan YZY Biopharma Co LtdNo. 666 Gaoxin RoadEast Lake High Tech Development ZoneWUHAN 430075ChinaCHN
- Phone+86 2 782668988
- Fax+86 2 768788819
- Websitehttps://www.yzybio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antengene Corp Ltd | 61.01m | -576.19m | 563.94m | 178.00 | -- | 0.5181 | -- | 9.24 | -0.9342 | -0.9342 | 0.0989 | 1.60 | 0.035 | 0.6597 | 1.57 | 303,530.50 | -33.06 | -53.57 | -37.16 | -58.94 | 84.84 | -- | -944.43 | -1,987.01 | 5.66 | -- | 0.1663 | -- | -57.97 | -- | 3.38 | -- | 202.03 | -- |
| JW (Cayman) Therapeutics Co Ltd | 188.17m | -683.18m | 610.65m | 323.00 | -- | 0.3784 | -- | 3.25 | -1.66 | -1.66 | 0.4562 | 3.89 | 0.0747 | 1.87 | 11.48 | 472,795.30 | -27.11 | -39.77 | -31.71 | -44.00 | 50.40 | -- | -363.06 | -1,316.81 | 2.76 | -- | 0.2043 | -- | 19.32 | -- | 9.23 | -- | -19.87 | -- |
| HighTide Therapeutics Inc | 0.00 | -653.43m | 633.17m | 68.00 | -- | 0.9741 | -- | -- | -1.40 | -1.40 | 0.00 | 1.26 | 0.00 | -- | -- | 0.00 | -87.01 | -- | -118.34 | -- | -- | -- | -- | -- | -- | -- | 0.0404 | -- | -- | -- | -393.76 | -- | -- | -- |
| Sunho Biologics Inc | 0.00 | -116.75m | 777.07m | 124.00 | -- | 1.30 | -- | -- | -0.5644 | -0.5644 | 0.00 | 3.81 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 14.77 | -300.76 | 0.0516 | -- | -- | -- | -155.25 | -- | -- | -- |
| Brii Biosciences Ltd | 0.00 | -288.84m | 782.34m | 95.00 | -- | 0.2510 | -- | -- | -0.3958 | -0.3958 | 0.00 | 4.26 | 0.00 | -- | -- | 0.00 | -8.89 | -- | -9.01 | -- | -- | -- | -- | -- | -- | -- | 0.007 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -336.47m | 926.25m | 201.00 | -- | 10.50 | -- | -- | -0.6539 | -0.6539 | 0.00 | 0.1715 | 0.00 | -- | -- | 0.00 | -35.21 | -37.42 | -55.75 | -45.48 | -- | -- | -- | -- | 0.3638 | -2.46 | 0.6119 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
| Genor Biopharma Holdings Ltd | 15.75m | -571.82m | 946.93m | 28.00 | -- | 0.8096 | -- | 60.14 | -1.13 | -1.13 | 0.031 | 2.25 | 0.0093 | 0.0178 | 0.2277 | 151,397.50 | -33.87 | -55.46 | -39.06 | -63.73 | 97.59 | 66.56 | -3,638.27 | -14,819.18 | 5.73 | -- | 0.003 | -- | -100.00 | -- | 7.65 | -- | -48.85 | -- |
| Wuhan YZY Biopharma Co Ltd | 0.00 | -199.71m | 1.06bn | 114.00 | -- | 19.69 | -- | -- | -1.05 | -1.05 | 0.00 | 0.2784 | 0.00 | -- | -- | 0.00 | -83.99 | -- | -230.17 | -- | -- | -- | -- | -- | 1.21 | -- | 0.7078 | -- | -- | -- | -1.50 | -- | -- | -- |
| TOT Biopharm International Co Ltd | 1.06bn | 9.76m | 1.31bn | 572.00 | 125.66 | 1.66 | 18.90 | 1.23 | 0.0135 | 0.0135 | 1.46 | 1.02 | 0.6899 | 2.44 | 6.40 | 1,921,852.00 | 0.6356 | -20.01 | 0.8392 | -25.21 | 72.02 | 74.74 | 0.9212 | -68.53 | 1.63 | 2.98 | 0.3465 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 25.23m | -393.79m | 1.40bn | 298.00 | -- | 1.42 | -- | 55.34 | -0.5073 | -0.5073 | 0.0325 | 1.25 | 0.016 | -- | 2.41 | 83,815.43 | -24.89 | -45.76 | -28.66 | -49.30 | 3.45 | -- | -1,560.88 | -372.22 | -- | -- | 0.1794 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| Mabpharm Ltd | 164.99m | -225.16m | 1.44bn | 297.00 | -- | 11.52 | -- | 8.75 | -0.0546 | -0.0546 | 0.04 | 0.0304 | 0.164 | 0.1937 | 3.26 | 475,468.60 | -22.38 | -21.42 | -31.11 | -27.49 | 86.91 | -- | -136.47 | -486.40 | 0.6836 | -22.44 | 0.679 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
Data as of Nov 08 2024. Currency figures normalised to Wuhan YZY Biopharma Co Ltd's reporting currency: Hong Kong Dollar HKD
